In:
Cancer, Wiley, Vol. 123, No. 18 ( 2017-09-15), p. 3568-3575
Abstract:
Autologous hematopoietic stem cell transplantation in patients with primary and relapsed/refractory multiple myeloma induces a response in a significant proportion of patients, even in those who are refractory to proteasome inhibitors and immunomodulatory agents.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v123.18
Language:
English
Publisher:
Wiley
Publication Date:
2017
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1